Neurofibroma Educational Series

The Comprehensive NF Center @ NYU presents:
Neurofibroma Educational Series: Neurofibromatosis type 2: an update

CART Transcript - Can be found Here

Event Information

Date: Tuesday, January 31, 2012
Presenter: John G. Pappas, MD
Title: Director of the NYU Clinical Genetic Services

Description

Neurofibromatosis type 2 is an autosomal dominant genetic condition associated with tumors of the nerve for hearing, and tumors of the membranes around the brain and spinal cord. People with this condition are born with one mutated copy of the NF2 gene in each cell. In about half of cases, the altered gene is inherited from an affected parent. The remaining cases result from new mutations in the NF2 gene and occur in people with no history of the disorder in their family.

This program included descriptions of the clinical features, advances and difficulties in molecular diagnosis, current treatment and controversies, simplified molecular pathways and drug development and the pertinent genetic counseling.

CART Transcript - CART Transcript is now available

Home | What Is NF2? | Medical Choices | Tumor Suppressors | Resources | Contact Us

NF2 NYC Support Group, New York
Email: Lori Davila at lori@nf2nycsupport.org
Copyright © 2008 - 2012

DISCLAIMER: www.nf2nycsupport.org is not run by medical experts, affiliated with any healthcare organization or any other company. No assurance can be made to the accuracy or completeness of the information provided here, the accuracy of other sites to which this site links, or of sites that link to this site. While we hope the information found on the www.nf2nycsupport.org site is helpful in offering suggestions in topics to discuss with your doctor, information found here should not be considered actual medical advice. Medical advice should always be sought by consultation with a medical professional.